Total Payments
$6,447
2024 Payments
$473.15
Companies
21
Transactions
452
Medicare Patients
6,730
Medicare Billing
$720,203
Payment Breakdown by Category
Food & Beverage$6,395 (99.2%)
Education$51.67 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,395 | 450 | 99.2% |
| Education | $51.67 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $1,282 | 108 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,163 | 99 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $528.49 | 41 | $0 (2023) |
| PFIZER INC. | $518.70 | 31 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $500.89 | 35 | $0 (2024) |
| Merck Sharp & Dohme LLC | $445.51 | 26 | $0 (2024) |
| Amgen Inc. | $307.73 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $289.74 | 18 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $257.50 | 10 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $209.05 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $473.15 | 22 | Novartis Pharmaceuticals Corporation ($157.61) |
| 2023 | $597.09 | 32 | Novartis Pharmaceuticals Corporation ($176.67) |
| 2022 | $956.61 | 72 | Novartis Pharmaceuticals Corporation ($224.04) |
| 2021 | $1,196 | 93 | Amarin Pharma Inc. ($422.73) |
| 2020 | $582.59 | 54 | Amarin Pharma Inc. ($266.15) |
| 2019 | $804.98 | 65 | Kowa Pharmaceuticals America, Inc. ($187.64) |
| 2018 | $843.84 | 57 | Amarin Pharma Inc. ($202.55) |
| 2017 | $992.94 | 57 | Novartis Pharmaceuticals Corporation ($249.60) |
All Payment Transactions
452 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.45 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $31.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Cardiology | ||||||
| 08/15/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: DIABETES | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/09/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/18/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardiology | ||||||
| 03/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiology | ||||||
| 03/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/29/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Cardiology | ||||||
| 02/22/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/01/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/18/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Cardiology | ||||||
| 01/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: DIABETES | ||||||
| 12/07/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/30/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/16/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,231 | 1,576 | $420,473 | $129,306 |
| 2022 | 25 | 1,744 | 2,363 | $498,019 | $192,599 |
| 2021 | 26 | 1,990 | 2,755 | $540,256 | $221,244 |
| 2020 | 25 | 1,765 | 2,303 | $371,103 | $177,054 |
Total Patients
6,730
Total Services
8,997
Medicare Billing
$720,203
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 204 | 361 | $106,852 | $40,483 | 37.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 134 | 136 | $79,363 | $22,960 | 28.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 127 | 129 | $55,007 | $21,404 | 38.9% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 68 | 68 | $37,833 | $14,384 | 38.0% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 39 | 39 | $21,314 | $6,823 | 32.0% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 113 | 119 | $45,836 | $6,819 | 14.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 206 | 363 | $29,706 | $4,726 | 15.9% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 68 | 68 | $13,729 | $3,058 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 25 | $3,875 | $1,814 | 46.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,856 | $1,694 | 43.9% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 68 | 68 | $18,107 | $1,469 | 8.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 19 | $1,771 | $890.43 | 50.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 12 | 15 | $1,136 | $865.13 | 76.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 15 | 16 | $478.40 | $464.16 | 97.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 15 | 16 | $249.28 | $236.48 | 94.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 16 | 18 | $250.02 | $236.16 | 94.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 13 | 14 | $242.20 | $230.44 | 95.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 19 | 22 | $241.12 | $227.70 | 94.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 18 | 21 | $184.59 | $159.81 | 86.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 18 | 19 | $174.00 | $150.90 | 86.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 11 | 12 | $122.52 | $114.24 | 93.2% |
| 83735 | Magnesium level | Office | 2023 | 14 | 15 | $146.70 | $98.55 | 67.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 246 | 482 | $126,998 | $55,468 | 43.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 194 | 198 | $97,475 | $35,662 | 36.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 191 | 195 | $77,933 | $35,336 | 45.3% |
About Dr. Ronald Stevens, M.D
Dr. Ronald Stevens, M.D is a Cardiovascular Disease healthcare provider based in Mineola, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639230758.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Stevens, M.D has received a total of $6,447 in payments from pharmaceutical and medical device companies, with $473.15 received in 2024. These payments were reported across 452 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($6,395).
As a Medicare-enrolled provider, Stevens has provided services to 6,730 Medicare beneficiaries, totaling 8,997 services with total Medicare billing of $720,203. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Mineola, NY
- Active Since 12/12/2006
- Last Updated 06/13/2012
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639230758
Products in Payments
- Vascepa (Drug) $1,282
- ENTRESTO (Drug) $885.58
- Livalo (Drug) $507.09
- XARELTO (Drug) $500.89
- ELIQUIS (Drug) $475.22
- VERQUVO (Drug) $445.51
- LEQVIO (Drug) $276.94
- JARDIANCE (Drug) $257.50
- PRALUENT (Drug) $209.05
- FARXIGA (Drug) $179.05
- Corlanor (Drug) $155.30
- Repatha (Biological) $152.43
- NEXLETOL (Drug) $135.96
- VIAGRA (Drug) $123.92
- BYSTOLIC (Drug) $105.29
- Ranexa (Drug) $104.32
- FUROSCIX (Drug) $84.71
- CHANTIX (Drug) $78.50
- BRILINTA (Drug) $55.44
- Mitra Clip system (Device) $47.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Mineola
Dr. Michelle Bloom, Md, MD
Cardiovascular Disease — Payments: $255,931
Cardiovascular Disease $255,931
Dr. Marilyn Chengot, Md, MD
Cardiovascular Disease — Payments: $16,150
Cardiovascular Disease $16,150
Giorgio Medranda, Md, MD
Cardiovascular Disease — Payments: $11,968
Cardiovascular Disease $11,968
Aasha Gopal, M.d, M.D
Cardiovascular Disease — Payments: $10,873
Cardiovascular Disease $10,873
Dr. Stephen Green, Md, MD
Cardiovascular Disease — Payments: $8,794
Cardiovascular Disease $8,794
Richard Smith, Md, MD
Cardiovascular Disease — Payments: $6,083
Cardiovascular Disease $6,083